Mesenchymal stromal cells and liver fibrosis: a complicated relationship-Reference-Cited by-同舟云学术

Mesenchymal stromal cells and liver fibrosis: a complicated relationship

Published:2016-09-06 Issue:12 Volume:30 Page:3905-3928
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Haldar Debashis¹²,Henderson Neil C.³,Hirschfield Gideon¹²,Newsome Philip N.¹²

Affiliation:

1. National Institute for Health ResearchBirmingham Liver Biomedical Research Unit and Centre for Liver Research University of Birmingham Birmingham United Kingdom

2. Liver UnitUniversity Hospital Birmingham National Health Service (NHS) Foundation Trust Birmingham United Kingdom

3. Medical Research Council (MRC) Centre for Inflammation ResearchQueens Medical Research Institute University of Edinburgh Edinburgh United Kingdom

Funder

Wellcome Trust

National Institute for Health Research

National Institute on Handicapped Research

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201600433R

Reference150 articles.

1. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

2. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis

3. Eurotransplant Statistics

4. Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

5. Reversal of cirrhosis: An achievable goal of hepatitis B antiviral therapy

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1H-NMR-based metabolomics to dissect the traditional Chinese medicine promotes mesenchymal stem cell homing as intervention in liver fibrosis in mouse model of Wilson’s disease;Journal of Pharmacy and Pharmacology;2024-03-01

2. Administration of AG490 decreases the senescence of umbilical cord-mesenchymal stem cells and promotes the cytotherapeutic effect in liver fibrosis;Cell Death Discovery;2023-07-28

3. Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside;Stem Cell Reviews and Reports;2023-07-27

4. TGFβ₁ priming enhances CXCR3‐mediated mesenchymal stromal cell engraftment to the liver and enhances anti‐inflammatory efficacy;Journal of Cellular and Molecular Medicine;2023-02-23

5. microRNAs ‐based diagnostic and therapeutic applications in liver fibrosis;WIREs RNA;2022-12-30